Ointment Akriderm Genta for external use, 30 g

Akriderm GENTA ointment for planks.

approx.

tube 30g

Name ENG

AKRIDERM GENTA

Clinical and pharmacological group

GCS for local use + antibiotic aminoglycoside

ATX code

Betamethasone in combination with antibiotics

Dosage

0.05% + 0.1% x 30g

Structure

1 gram contains 0.64 mg of betamethasone dipropionate (which is equivalent to 0.5 mg of betamethasone) and gentamicin sulfate - 1 mg.

Indications

Treatment of steroid-sensitive dermatoses complicated by primary and / or secondary bacterial infection, eczema (atopic, childhood, coin-like), limited and diffuse allergic dermatoses, including those complicated by an infection sensitive to gentamicin, dermatitis (simple and allergic), atopic dermatitis, solar dermatitis, exfoliative and radiation dermatitis, diaper rash, psoriasis, itching.

INN / Active ingredient

Betamethasone, gentamicin

Contraindications

Hypersensitivity to drug components.

Skin tuberculosis, viral skin infections, vaccinations, perioral dermatitis, rosacea (rosacea).

Storage conditions and periods

At a temperature of 15-25 degrees.

Expiration date: 2 years

Specifications

Category

Psoriasis

Scope of the drug

Dermatology

,

Leather

Release form

Ointment

Manufacturer country

Russia

Package quantity, pcs

one

Scope of application

Dermatology

Minimum age from

2 years old

Way of introduction

Outwardly

Vacation conditions

Without recipe

Brand name

Akrikhin

The amount of the dosage form in the primary package

30 g

Primary packaging type

Tuba

Type of consumer packaging

Pack of cardboard

Anatomical and therapeutic characteristics

D07CC01 Betamethasone, in combination with antibiotics

Dosage form

Ointment for external use

Expiration date in days

730

The target audience

Children

Package weight, g

thirty

Mode of application

:

The preparation Akriderm GENTA is applied in a thin layer on the inflamed surface twice a day, rubbing lightly.

In milder cases, a single use is sufficient.

The duration of treatment is determined individually and depends on the nosological form and severity of the disease is, as a rule, 1-2 (rarely 4 weeks).

< br> If a long course of therapy is required, it is recommended to use the drug less often, for example, every other day.

< br> In the treatment of chronic diseases under the constant supervision of a physician, treatment should be continued for some time after the disappearance of all symptoms in order to avoid recurrence of the disease.

< br> The use of the drug in children under 12 years of age is carried out under the supervision of the attending physician.

Pharmaco-therapeutic group

:

Topical glucocorticosteroid + antibiotic aminoglycoside

Dosage (volume) of the substance in the preparation

:

0.64 mg betamethasone dipropionate (equivalent to 0.5 mg betamethasone) and gentamicin sulfate - 1 mg